Cytori Therapeutics Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (1996)
Status: Acquired by Kensey Nash Corporation (2007) → now Thermo Fisher Scientific (2017)

Organization Overview

First Clinical Trial
2007
NCT00442806
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cytori Therapeutics, Inc., | Plus Therapeutics